
#421Medicine & HealthFront Page15 November 2025
Targeted Therapies Herald New Era for Autoimmune Bleeding Disorder
Treatment for Immune thrombocytopenia (ITP), an autoimmune disorder causing low platelet counts, is rapidly evolving. Scientists are moving beyond broad immunosuppressants towards a new generation of targeted therapies that promise improved efficacy, better safety, and the potential for lasting remission without continuous treatment.
By Charbel, Rizkallah, Fawaz, El Khoury, Hodroj, Taher